BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 28620750)

  • 21. Major complications from radiotherapy following treatment for atypical meningiomas.
    Dawley T; Rana Z; Abou-Al-Shaar H; Goenka A; Schulder M
    Neurosurg Focus; 2019 Jun; 46(6):E5. PubMed ID: 31153147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
    Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
    Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
    Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
    J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 May; 13(1):86. PubMed ID: 29739417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas.
    Li D; Jiang P; Xu S; Li C; Xi S; Zhang J; Chen Y; Jiang X; Zhang X; Sai K; Wang J; Mou Y; Ke C; Chen Z
    J Neurooncol; 2019 Oct; 145(1):125-134. PubMed ID: 31493161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome.
    Kessel KA; Weber W; Yakushev I; Fischer H; Voglhuber T; Diehl C; Straube C; Zimmer C; Wiestler B; Gempt J; Meyer B; Combs SE
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1391-1399. PubMed ID: 31758226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
    Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
    Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
    World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma knife stereotactic radiosurgery for atypical and malignant meningiomas.
    Mori Y; Tsugawa T; Hashizume C; Kobayashi T; Shibamoto Y
    Acta Neurochir Suppl; 2013; 116():85-9. PubMed ID: 23417463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of failure after stereotactic radiotherapy of intracranial meningioma.
    Askoxylakis V; Zabel-du Bois A; Schlegel W; Debus J; Huber P; Milker-Zabel S
    J Neurooncol; 2010 Jul; 98(3):367-72. PubMed ID: 20012910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy.
    Zhi M; Girvigian MR; Miller MJ; Chen JC; Schumacher AJ; Rahimian J; Lodin K
    World Neurosurg; 2019 Feb; 122():e1153-e1161. PubMed ID: 30447464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management trends for anaplastic meningioma with adjuvant radiotherapy and predictors of long-term survival.
    Alhourani A; Aljuboori Z; Yusuf M; Woo SY; Hattab EM; Andaluz N; Williams BJ
    Neurosurg Focus; 2019 Jun; 46(6):E4. PubMed ID: 31153143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic radiotherapy of benign meningioma in the elderly: clinical outcome and toxicity in 121 patients.
    Fokas E; Henzel M; Surber G; Hamm K; Engenhart-Cabillic R
    Radiother Oncol; 2014 Jun; 111(3):457-62. PubMed ID: 24813096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.
    Sajja R; Barnett GH; Lee SY; Harnisch G; Stevens GH; Lee J; Suh JH
    Technol Cancer Res Treat; 2005 Dec; 4(6):675-82. PubMed ID: 16292888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas.
    Maranzano E; Draghini L; Casale M; Arcidiacono F; Anselmo P; Trippa F; Giorgi C
    Strahlenther Onkol; 2015 Dec; 191(12):953-60. PubMed ID: 26490452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study.
    Sheehan JP; Starke RM; Kano H; Kaufmann AM; Mathieu D; Zeiler FA; West M; Chao ST; Varma G; Chiang VL; Yu JB; McBride HL; Nakaji P; Youssef E; Honea N; Rush S; Kondziolka D; Lee JY; Bailey RL; Kunwar S; Petti P; Lunsford LD
    J Neurosurg; 2014 Jun; 120(6):1268-77. PubMed ID: 24678777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy after surgery for benign cerebral meningioma.
    Soyuer S; Chang EL; Selek U; Shi W; Maor MH; DeMonte F
    Radiother Oncol; 2004 Apr; 71(1):85-90. PubMed ID: 15066300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractionated stereotactic radiotherapy in the treatment of exclusive cavernous sinus meningioma: functional outcome, local control, and tolerance.
    Brell M; Villà S; Teixidor P; Lucas A; Ferrán E; Marín S; Acebes JJ
    Surg Neurol; 2006 Jan; 65(1):28-33; discussion 33-4. PubMed ID: 16378847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Image-Guided Robotic Radiosurgery for Treatment of Recurrent Grade II and III Meningiomas. A Single-Center Study.
    Acker G; Meinert F; Conti A; Kufeld M; Jelgersma C; Nguyen P; Kluge A; Lukas M; Loebel F; Pasemann D; Kaul D; Budach V; Vajkoczy P; Senger C
    World Neurosurg; 2019 Nov; 131():e96-e107. PubMed ID: 31306844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The "Combo" radiotherapy treatment for high-risk grade 2 meningiomas: dose escalation and initial safety and efficacy analysis.
    Pontoriero A; Critelli P; Conti A; Cardali S; Angileri FF; Germanò A; Lillo S; Carretta A; Brogna A; Santacaterina A; Parisi S; Pergolizzi S
    J Neurooncol; 2023 Jan; 161(2):203-214. PubMed ID: 35927392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.